Dexmedetomidine premix formulation

CAFC
  • US 8,338,470 B1
  • Filed: 07/03/2012
  • Issued: 12/25/2012
  • Est. Priority Date: 01/04/2012
  • Status: Active Grant
First Claim
Patent Images

1. A ready to use liquid pharmaceutical composition for parenteral administration to a subject, comprising dexmedetomidine or a pharmaceutically acceptable salt thereof at a concentration of about 0.005 to about 50 μ

  • g/mL disposed within a sealed glass container.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×